TY - JOUR
T1 - Comprehensive geriatric assessment in 326 older women with early breast cancer
AU - Okonji, D. O.
AU - Sinha, R.
AU - Phillips, I.
AU - Fatz, D.
AU - Ring, A.
N1 - Publisher Copyright:
© 2017 Cancer Research UK. All rights reserved.
PY - 2017/9/26
Y1 - 2017/9/26
N2 - Background:One-third of new early breast cancer diagnoses occur in women over 70 years old. However, older women are less likely to receive radical curative treatments. This study prospectively evaluated a cohort of older women using a Comprehensive Geriatric Assessment (CGA) to determine whether fitness explained the apparent under-treatment in this patient group.Methods:In this multi-centre prospective study, patients aged ≥70 years with Stages I-III breast cancer underwent a pretreatment baseline CGA consisting of eight assessment tools. Patients were defined as 'fit' if they had normal score in seven out of eight of the assessment tools. a 'High risk' patients were defined as those with grade 3, ER negative, HER2 positive, or node positive breast cancer.Results:Data on 326 patients were available for full analysis. The median age was 77 years. In all, 182 (56%) of the total population were defined as high risk, with 49%, 61% and 53% of those in the 70-74, 75-84 and ≥85 years age groups respectively having high risk tumours. A total of 301 patients had sufficient CGA records of whom 131 (44%) were reported as fit, with 34%, 54% and 12% of them in the 70-74, 75-84 and ≥85 years age groups respectively. More fit than unfit patients underwent primary breast surgery (100% vs 91%, P=0.0002), axillary surgery (92% vs 84%, P=0.0340), and adjuvant chemotherapy for high-risk disease (51% vs 20%, P=0.0001). Rates of adjuvant radiotherapy after wide local excision were not significantly different (88% vs 90% respectively, P=0.8195).Conclusions:In this study, all women ≥70 years deemed fit by CGA underwent primary surgery. Nearly 50% of fit women with high-risk disease did not receive adjuvant chemotherapy suggesting under treatment in this group.
AB - Background:One-third of new early breast cancer diagnoses occur in women over 70 years old. However, older women are less likely to receive radical curative treatments. This study prospectively evaluated a cohort of older women using a Comprehensive Geriatric Assessment (CGA) to determine whether fitness explained the apparent under-treatment in this patient group.Methods:In this multi-centre prospective study, patients aged ≥70 years with Stages I-III breast cancer underwent a pretreatment baseline CGA consisting of eight assessment tools. Patients were defined as 'fit' if they had normal score in seven out of eight of the assessment tools. a 'High risk' patients were defined as those with grade 3, ER negative, HER2 positive, or node positive breast cancer.Results:Data on 326 patients were available for full analysis. The median age was 77 years. In all, 182 (56%) of the total population were defined as high risk, with 49%, 61% and 53% of those in the 70-74, 75-84 and ≥85 years age groups respectively having high risk tumours. A total of 301 patients had sufficient CGA records of whom 131 (44%) were reported as fit, with 34%, 54% and 12% of them in the 70-74, 75-84 and ≥85 years age groups respectively. More fit than unfit patients underwent primary breast surgery (100% vs 91%, P=0.0002), axillary surgery (92% vs 84%, P=0.0340), and adjuvant chemotherapy for high-risk disease (51% vs 20%, P=0.0001). Rates of adjuvant radiotherapy after wide local excision were not significantly different (88% vs 90% respectively, P=0.8195).Conclusions:In this study, all women ≥70 years deemed fit by CGA underwent primary surgery. Nearly 50% of fit women with high-risk disease did not receive adjuvant chemotherapy suggesting under treatment in this group.
UR - http://www.scopus.com/inward/record.url?scp=85029896359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029896359&partnerID=8YFLogxK
U2 - 10.1038/bjc.2017.257
DO - 10.1038/bjc.2017.257
M3 - Article
C2 - 28797032
AN - SCOPUS:85029896359
SN - 0007-0920
VL - 117
SP - 925
EP - 931
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 7
ER -